Treatment Information

Back

Lung Cancer treatment details. Chemotherapy.

University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States.

Survival: monthsCountry:United States
Toxiciy Grade:4City/State/Province:Chapel Hill, North Carolina
Treatments:ChemotherapyHospital:University of North Carolina, Chapel Hill
Drugs:Journal:Link
Date:Oct 2002

Description:

Patients: This Phase II trial involved 40 patients with advanced (stage IIIB or IV) non-small cell lung carcinoma.

Treatment: The treatment consisted of a three-drug combination of irinotecan (CPT-11, Camptosar), paclitaxel (taxol), and carboplatin (paraplatin).

Toxicity: Grade 2-4 toxicities included hematologic, diarrhea, vomiting, dyspnea, and dehydration. Other toxicities (grade 2-3 included) alopecia, asthenia, nausea, arthralgia, myalgia, and neuropathy.

Results: The median survival was 12.5 months.

Support: This study was supported in part by a grant from Pharmacia Corporation. Pharmacia Corporation markets irinotecan (CPT-11).

Correspondence: Mark A. Socinski, MD




Back